218 related articles for article (PubMed ID: 21123859)
1. Prognostic evaluation of Ki67 threshold value in canine oral melanoma.
Bergin IL; Smedley RC; Esplin DG; Spangler WL; Kiupel M
Vet Pathol; 2011 Jan; 48(1):41-53. PubMed ID: 21123859
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical characterization and evaluation of prognostic factors in canine oral melanomas with osteocartilaginous differentiation.
Sánchez J; Ramirez GA; Buendia AJ; Vilafranca M; Martinez CM; Altimira J; Navarro JA
Vet Pathol; 2007 Sep; 44(5):676-82. PubMed ID: 17846240
[TBL] [Abstract][Full Text] [Related]
3. PCNA and Ki67 proliferation markers as criteria for prediction of clinical behaviour of melanocytic tumours in cats and dogs.
Roels S; Tilmant K; Ducatelle R
J Comp Pathol; 1999 Jul; 121(1):13-24. PubMed ID: 10373290
[TBL] [Abstract][Full Text] [Related]
4. The histologic and epidemiologic bases for prognostic considerations in canine melanocytic neoplasia.
Spangler WL; Kass PH
Vet Pathol; 2006 Mar; 43(2):136-49. PubMed ID: 16537931
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of clinico-pathological criteria and the Ki67 index as prognostic indicators in canine insulinoma.
Buishand FO; Kik M; Kirpensteijn J
Vet J; 2010 Jul; 185(1):62-7. PubMed ID: 20570189
[TBL] [Abstract][Full Text] [Related]
6. Canine gastrointestinal stromal tumors: immunohistochemical expression of CD34 and examination of prognostic indicators including proliferation markers Ki67 and AgNOR.
Gillespie V; Baer K; Farrelly J; Craft D; Luong R
Vet Pathol; 2011 Jan; 48(1):283-91. PubMed ID: 20826846
[TBL] [Abstract][Full Text] [Related]
7. Analysis of KIT expression and KIT exon 11 mutations in canine oral malignant melanomas.
Murakami A; Mori T; Sakai H; Murakami M; Yanai T; Hoshino Y; Maruo K
Vet Comp Oncol; 2011 Sep; 9(3):219-24. PubMed ID: 21848624
[TBL] [Abstract][Full Text] [Related]
8. Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma.
Gimotty PA; Van Belle P; Elder DE; Murry T; Montone KT; Xu X; Hotz S; Raines S; Ming ME; Wahl P; Guerry D
J Clin Oncol; 2005 Nov; 23(31):8048-56. PubMed ID: 16258103
[TBL] [Abstract][Full Text] [Related]
9. Fascin-1 expression in canine cutaneous and oral melanocytic tumours.
Yamada N; Mori T; Murakami M; Noguchi S; Sakai H; Akao Y; Maruo K
Vet Comp Oncol; 2012 Dec; 10(4):303-11. PubMed ID: 22236355
[TBL] [Abstract][Full Text] [Related]
10. Galectin-3 Expression Correlates with Post-surgical Survival in Canine Oral Melanomas.
Vargas THM; Pulz LH; Ferro DG; Sobral RA; Venturini MAFA; Corrêa HL; Strefezzi RF
J Comp Pathol; 2019 Nov; 173():49-57. PubMed ID: 31812173
[TBL] [Abstract][Full Text] [Related]
11. Lack of prognostic significance of angiogenesis in canine melanocytic tumours.
Cuitiño MC; Massone AR; Idiart JR
J Comp Pathol; 2012; 147(2-3):147-52. PubMed ID: 22520819
[TBL] [Abstract][Full Text] [Related]
12. Expression of monocarboxylate transporter 1 in oral and ocular canine melanocytic tumors.
Shimoyama Y; Akihara Y; Kirat D; Iwano H; Hirayama K; Kagawa Y; Ohmachi T; Matsuda K; Okamoto M; Kadosawa T; Yokota H; Taniyama H
Vet Pathol; 2007 Jul; 44(4):449-57. PubMed ID: 17606506
[TBL] [Abstract][Full Text] [Related]
13. PDGFRs expression in dogs affected by malignant oral melanomas: correlation with prognosis.
Iussich S; Maniscalco L; Di Sciuva A; Iotti B; Morello E; Martano M; Gattino F; Buracco P; De Maria R
Vet Comp Oncol; 2017 Jun; 15(2):462-469. PubMed ID: 26833575
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 immunohistochemical expression and somatic mutations in canine oral melanoma.
Zamboni C; Brocca G; Ferraresso S; Ferro S; Sammarco A; Dal Corso C; Iussich S; de Andres PJ; Martìnez de Merlo EM; Cavicchioli L; Zappulli V; Castagnaro M
Vet Comp Oncol; 2020 Jun; 18(2):231-238. PubMed ID: 31503380
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression and prognostic significance of MAGE-A in canine oral malignant melanoma.
Guillén A; Stiborova K; Ressel L; Blackwood L; Finotello R; Amores-Fuster I; Jama N; Killick D
Res Vet Sci; 2021 Jul; 137():226-234. PubMed ID: 34023546
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2 expression is related with localization, proliferation, and overall survival in canine melanocytic neoplasms.
Martínez CM; Peñafiel-Verdú C; Vilafranca M; Ramírez G; Méndez-Gallego M; Buendía AJ; Sánchez J
Vet Pathol; 2011 Nov; 48(6):1204-11. PubMed ID: 21292918
[TBL] [Abstract][Full Text] [Related]
17. Comparison between Ki-67 index and mitotic index for predicting outcome in canine mast cell tumours.
van Lelyveld S; Warland J; Miller R; Maw H; Foale R; Goodfellow M; Dobson J
J Small Anim Pract; 2015 May; 56(5):312-9. PubMed ID: 25728289
[TBL] [Abstract][Full Text] [Related]
18. Association of Ki67 index with prognosis for intermediate-grade canine cutaneous mast cell tumours.
Maglennon GA; Murphy S; Adams V; Miller J; Smith K; Blunden A; Scase TJ
Vet Comp Oncol; 2008 Dec; 6(4):268-74. PubMed ID: 19178685
[TBL] [Abstract][Full Text] [Related]
19. Prognostic markers for canine melanocytic neoplasms: a comparative review of the literature and goals for future investigation.
Smedley RC; Spangler WL; Esplin DG; Kitchell BE; Bergman PJ; Ho HY; Bergin IL; Kiupel M
Vet Pathol; 2011 Jan; 48(1):54-72. PubMed ID: 21266721
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical diagnosis of canine oral amelanotic melanocytic neoplasms.
Smedley RC; Lamoureux J; Sledge DG; Kiupel M
Vet Pathol; 2011 Jan; 48(1):32-40. PubMed ID: 21078882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
